Qinxue Hu Selected Research

Qinxue Hu Research Topics

Disease

27	Infections 01/2021 - 03/2003
10	Virus Diseases (Viral Diseases) 01/2022 - 05/2013
3	COVID-19 10/2021 - 01/2021
3	Zika Virus Infection 01/2020 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2018
1	Delirium 12/2022
1	Emergence Delirium 12/2022
1	Acute Kidney Injury (Acute Renal Failure) 12/2022
1	Critical Illness (Critically Ill) 01/2021
1	Wilms Tumor (Wilm's Tumor) 12/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2019
1	Microcephaly 01/2018
1	Congenital Abnormalities (Deformity) 01/2018
1	Neuroinflammatory Diseases 01/2018
1	Guillain-Barre Syndrome 01/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2016
1	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2016
1	Body Weight (Weight, Body) 09/2015
1	Persistent Infection 11/2013
1	Human Influenza (Influenza) 04/2012
1	Cytokine Release Syndrome 09/2011
1	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2010
1	Inflammation (Inflammations) 01/2009
1	HIV Infections (HIV Infection) 01/2009
1	Severe Acute Respiratory Syndrome 01/2009

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2012
5	VaccinesIBA 01/2021 - 01/2009
5	Messenger RNA (mRNA)IBA 01/2020 - 06/2012
4	Glycoproteins (Glycoprotein)IBA 01/2016 - 01/2009
3	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2016
3	Chemokine CCL5IBA 01/2018 - 07/2005
3	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2016 - 09/2012
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2018
2	Viral ProteinsIBA 09/2018 - 01/2018
2	AntibodiesIBA 09/2017 - 12/2014
2	CytokinesIBA 09/2011 - 01/2009
2	Anti-Infective Agents (Microbicides)IBA 04/2004 - 03/2003
1	Dexmedetomidine FDA Link 12/2022
1	Aquaporin 1IBA 01/2022
1	Single-Domain AntibodiesIBA 10/2021
1	AntigensIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Member 14 Tumor Necrosis Factor ReceptorsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Connective Tissue Growth FactorIBA 12/2020
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 01/2020
1	InterferonsIBA 01/2020
1	Dynamins (Dynamin)IBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	Codon (Codons)IBA 01/2018
1	LigandsIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 12/2016
1	UbiquitinIBA 12/2016
1	Lysine (L-Lysine)FDA Link 12/2016
1	Mannose (D-Mannose)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Single-Stranded DNA (DNA, Single Stranded)IBA 01/2016
1	CRISPR-Associated Protein 9IBA 08/2015
1	ChemokinesIBA 07/2015
1	Poly I-CIBA 04/2015
1	Bone Marrow Stromal Antigen 2IBA 01/2015
1	IntegrinsIBA 12/2014
1	C-Type Lectins (C-Type Lectin)IBA 06/2014
1	Viral AntigensIBA 11/2013
1	Viral RNAIBA 11/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 05/2013
1	clonidine-displacing substance (ClDS)IBA 09/2012
1	CCAAT-Enhancer-Binding ProteinsIBA 06/2012
1	Chemokine CXCL9IBA 06/2012
1	Polysaccharides (Glycans)IBA 10/2011
1	CC ChemokinesIBA 12/2010
1	Interferon-gamma (Interferon, gamma)IBA 01/2009
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2009
1	DNA VaccinesIBA 01/2009
1	cyanovirin NIBA 01/2009
1	Interleukin-4 (Interleukin 4)IBA 01/2009
1	Chemokine CXCL12IBA 01/2009
1	Pertussis ToxinIBA 12/2006
1	BMS-378806IBA 11/2005
1	CD4-IgG(2)IBA 04/2004
1	Monoclonal AntibodiesIBA 03/2003

Therapy/Procedure

2	Intranasal Administration 10/2021 - 06/2010
2	Therapeutics 11/2019 - 01/2016
1	Length of Stay 12/2022
1	Lung Transplantation 01/2021
1	Intraperitoneal Injections 09/2018
1	Injections 09/2015
1	Quantum Dots (Quantum Dot) 05/2013
1	Intravaginal Administration 03/2003